berberine has been researched along with Glioma in 10 studies
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The cytotoxicity of berberine on C6 rat glioma cells indicated that berberine induced morphological changes and caused cell death through G2/M arrest and apoptosis." | 7.75 | Involvement of reactive oxygen species and caspase-dependent pathway in berberine-induced cell cycle arrest and apoptosis in C6 rat glioma cells. ( Chen, GW; Chen, TC; Chiu, TH; Chung, JG; Hsia, TC; Lai, KC; Liao, CL; Lin, HJ; Lin, JJ; Tang, YJ; Yang, JS, 2009) |
| " Here, we investigated the effect of the natural alkaloid berberine on As2O3-mediated inhibition of cancer cell migration using rat and human glioma cell lines." | 7.74 | Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. ( Chou, FP; Kuo, HC; Lin, TH; Lu, FJ, 2008) |
| "Berberine is a protoberberine alkaloid with wide range of pharmacological activities, applicable to various pathological conditions." | 6.72 | Therapeutic Potential of Berberine in the Treatment of Glioma: Insights into Its Regulatory Mechanisms. ( Asemi, Z; Behnam, M; Mirzaei, H; Pourattar, MA; Razavi, ZS; Tamtaji, OR, 2021) |
| "Chemotherapy is a conventional treatment for glioma, but its efficacy is greatly limited due to low blood-brain barrier (BBB) permeability and lack of specificity." | 5.72 | Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma. ( Chen, J; Hai, L; Liu, Q; Lu, R; Wang, S; Wu, Y; Yang, C; Yang, Z, 2022) |
| "Berberine could inhibit the migration and invasion of glioma cells by suppressing the TGF-β1/COL11A1 pathway and changes actin cytoskeleton arrangement." | 5.72 | Berberine inhibits glioma cell migration and invasion by suppressing TGF-β1/COL11A1 pathway. ( Cao, J; Chen, Y; Gao, H; Huang, H; Lai, J; Li, C; Liu, Z; Sun, Y; Zhan, Z; Zhang, C, 2022) |
| "Berberine is a promising natural drug that has a potential therapeutic effect on neurodegenerative diseases." | 5.56 | Berberine Induces CYP2J2 Expression in Human U251 Glioma Cells via Regulation of Peroxisome Proliferator-Activated Receptor Alpha. ( Gong, J; Shi, J; Wang, J; Wang, S; Yu, S; Yu, X, 2020) |
| "Berberine (BBR) was the potential drug for anti-tumor in glioma cells." | 5.56 | Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial Pathway. ( An, J; Dong, W; He, Y; Jia, X; Jia, Y; Liu, K; Ma, X; Pan, Y; Sheng, J; Wang, B; Wang, J; Wang, S; Wang, X; Wu, Y; Yu, D; Yu, W; Zhao, Y; Zhu, W, 2020) |
| "The cytotoxicity of berberine on C6 rat glioma cells indicated that berberine induced morphological changes and caused cell death through G2/M arrest and apoptosis." | 3.75 | Involvement of reactive oxygen species and caspase-dependent pathway in berberine-induced cell cycle arrest and apoptosis in C6 rat glioma cells. ( Chen, GW; Chen, TC; Chiu, TH; Chung, JG; Hsia, TC; Lai, KC; Liao, CL; Lin, HJ; Lin, JJ; Tang, YJ; Yang, JS, 2009) |
| " Here, we investigated the effect of the natural alkaloid berberine on As2O3-mediated inhibition of cancer cell migration using rat and human glioma cell lines." | 3.74 | Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. ( Chou, FP; Kuo, HC; Lin, TH; Lu, FJ, 2008) |
| "Berberine is a protoberberine alkaloid with wide range of pharmacological activities, applicable to various pathological conditions." | 2.72 | Therapeutic Potential of Berberine in the Treatment of Glioma: Insights into Its Regulatory Mechanisms. ( Asemi, Z; Behnam, M; Mirzaei, H; Pourattar, MA; Razavi, ZS; Tamtaji, OR, 2021) |
| "Chemotherapy is a conventional treatment for glioma, but its efficacy is greatly limited due to low blood-brain barrier (BBB) permeability and lack of specificity." | 1.72 | Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma. ( Chen, J; Hai, L; Liu, Q; Lu, R; Wang, S; Wu, Y; Yang, C; Yang, Z, 2022) |
| "Berberine could inhibit the migration and invasion of glioma cells by suppressing the TGF-β1/COL11A1 pathway and changes actin cytoskeleton arrangement." | 1.72 | Berberine inhibits glioma cell migration and invasion by suppressing TGF-β1/COL11A1 pathway. ( Cao, J; Chen, Y; Gao, H; Huang, H; Lai, J; Li, C; Liu, Z; Sun, Y; Zhan, Z; Zhang, C, 2022) |
| "Berberine is a promising natural drug that has a potential therapeutic effect on neurodegenerative diseases." | 1.56 | Berberine Induces CYP2J2 Expression in Human U251 Glioma Cells via Regulation of Peroxisome Proliferator-Activated Receptor Alpha. ( Gong, J; Shi, J; Wang, J; Wang, S; Yu, S; Yu, X, 2020) |
| "Berberine (BBR) was the potential drug for anti-tumor in glioma cells." | 1.56 | Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial Pathway. ( An, J; Dong, W; He, Y; Jia, X; Jia, Y; Liu, K; Ma, X; Pan, Y; Sheng, J; Wang, B; Wang, J; Wang, S; Wang, X; Wu, Y; Yu, D; Yu, W; Zhao, Y; Zhu, W, 2020) |
| "Berberine was evaluated for antitumor activity against malignant brain tumors." | 1.28 | Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors. ( Dougherty, DV; Rosenblum, ML; Zhang, RX, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, C | 1 |
| Yang, Z | 1 |
| Wang, S | 3 |
| Chen, J | 1 |
| Liu, Q | 1 |
| Hai, L | 1 |
| Lu, R | 1 |
| Wu, Y | 2 |
| Sun, Y | 2 |
| Huang, H | 2 |
| Zhan, Z | 1 |
| Gao, H | 1 |
| Zhang, C | 2 |
| Lai, J | 1 |
| Cao, J | 2 |
| Li, C | 1 |
| Chen, Y | 2 |
| Liu, Z | 1 |
| Yu, X | 1 |
| Wang, J | 2 |
| Gong, J | 1 |
| Shi, J | 1 |
| Yu, S | 1 |
| Asemi, Z | 1 |
| Behnam, M | 1 |
| Pourattar, MA | 1 |
| Mirzaei, H | 1 |
| Razavi, ZS | 1 |
| Tamtaji, OR | 1 |
| An, J | 1 |
| Dong, W | 1 |
| Wang, X | 1 |
| Sheng, J | 1 |
| Jia, Y | 1 |
| He, Y | 1 |
| Ma, X | 1 |
| Yu, D | 1 |
| Jia, X | 1 |
| Wang, B | 1 |
| Yu, W | 1 |
| Liu, K | 1 |
| Zhao, Y | 1 |
| Zhu, W | 1 |
| Pan, Y | 1 |
| Yu, J | 1 |
| Liu, X | 2 |
| Li, G | 1 |
| Chen, TC | 1 |
| Lai, KC | 1 |
| Yang, JS | 1 |
| Liao, CL | 1 |
| Hsia, TC | 1 |
| Chen, GW | 1 |
| Lin, JJ | 1 |
| Lin, HJ | 1 |
| Chiu, TH | 1 |
| Tang, YJ | 1 |
| Chung, JG | 1 |
| Lin, TH | 1 |
| Kuo, HC | 1 |
| Chou, FP | 1 |
| Lu, FJ | 1 |
| Novak, JE | 1 |
| Agranoff, BW | 1 |
| Fisher, SK | 1 |
| Zhang, RX | 1 |
| Dougherty, DV | 1 |
| Rosenblum, ML | 1 |
1 review available for berberine and Glioma
| Article | Year |
|---|---|
Therapeutic Potential of Berberine in the Treatment of Glioma: Insights into Its Regulatory Mechanisms.
Topics: Animals; Antineoplastic Agents, Phytogenic; Autophagy; Berberine; Brain Neoplasms; Cell Proliferatio | 2021 |
9 other studies available for berberine and Glioma
| Article | Year |
|---|---|
Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma.
Topics: Berberine; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Folic Acid; Glioma; Humans; Hyd | 2022 |
Berberine inhibits glioma cell migration and invasion by suppressing TGF-β1/COL11A1 pathway.
Topics: Animals; Berberine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Collagen Type XI; | 2022 |
Berberine Induces CYP2J2 Expression in Human U251 Glioma Cells via Regulation of Peroxisome Proliferator-Activated Receptor Alpha.
Topics: Berberine; Cell Line, Tumor; Cell Survival; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; | 2020 |
Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial Pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Berberine; Biological Transport; Blood-Brain Barrier; Bra | 2020 |
Oncosis-like cell death is induced by berberine through ERK1/2-mediated impairment of mitochondrial aerobic respiration in gliomas.
Topics: Adenosine Triphosphate; Aerobiosis; Animals; Apoptosis; Autophagy; Berberine; Brain Neoplasms; Cell | 2018 |
Involvement of reactive oxygen species and caspase-dependent pathway in berberine-induced cell cycle arrest and apoptosis in C6 rat glioma cells.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Berberine; Blotting, Western; Calcium; Caspase Inhib | 2009 |
Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.
Topics: Actins; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Berberine; Cell Line, Tumor; C | 2008 |
Increased expression of Galpha(q/11) and of phospholipase-Cbeta1/4 in differentiated human NT2-N neurons: enhancement of phosphoinositide hydrolysis.
Topics: Animals; Antineoplastic Agents; Berberine; Brain; Cell Differentiation; Glioma; GTP-Binding Protein | 2000 |
Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Berberine; Brain Neo | 1990 |